Radioprotective efficacy of dipyridamole and AMP combination in fractionated radiation regimen, and its dependence on the time of administration of the drugs prior to irradiation
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
8789320
Knihovny.cz E-resources
- MeSH
- Adenosine Monophosphate pharmacology MeSH
- Survival Analysis MeSH
- Cell Division drug effects radiation effects MeSH
- Time Factors MeSH
- Dipyridamole pharmacology MeSH
- Hematopoietic System cytology drug effects radiation effects MeSH
- Hypoxia drug therapy physiopathology MeSH
- Drug Therapy, Combination MeSH
- Mice, Inbred C57BL MeSH
- Mice MeSH
- Radiation-Protective Agents pharmacology MeSH
- Drug Administration Schedule MeSH
- Body Weight MeSH
- Vasodilator Agents pharmacology MeSH
- Organ Size MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adenosine Monophosphate MeSH
- Dipyridamole MeSH
- Radiation-Protective Agents MeSH
- Vasodilator Agents MeSH
We have recently demonstrated that the combined administration of dipyridamole and adenosine monophospate to mice induces radioprotective effects in terms of postirradiation haemopoietic recovery in animals irradiated with a single dose. The aim of the present experiments was to investigate the radioprotective ability of the drug combination under conditions of fractionated radiation treatment. It has been shown that administration of drugs either 15 or 60 min before each of the five daily 3-Gy doses of gamma-radiation enhances haemopoietic recovery and survival of mice exposed to an additional "top-up" dose of 3.5 Gy. Furthermore, it has been ascertained that the regimen using administration of the drugs 60 min prior to irradiation is more effective than administration of the drugs 15 min prior to irradiation. Due to the evidence that administration of the drugs 15 min prior to irradiation protects the organism mainly via mechanisms of systemic hypoxia while the pretreatment 60 min before irradiation avoids the role of hypoxia and mainly induces cell proliferation effects, our results suggest a more effective protective role of mechanisms stimulating haemopoiesis under conditions of fractionated radiation. The data may provide a basis for more rational use of radioprotection in fractionated radiation regimens.
The role of adenosine receptor agonists in regulation of hematopoiesis